Guggenheim Capital LLC Sells 2,534 Shares of M.D.C. Holdings, Inc. (NYSE:MDC)

Guggenheim Capital LLC lowered its stake in M.D.C. Holdings, Inc. (NYSE:MDC – Get Rating) by 9.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 22,999 shares of the construction company’s stock after selling 2,534 shares during the quarter. Guggenheim Capital LLC’s holdings in M.D.C. were worth $630,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in MDC. Raymond James & Associates boosted its stake in M.D.C. by 47.2% in the 3rd quarter. Raymond James & Associates now owns 905,190 shares of the construction company’s stock worth $24,820,000 after purchasing an additional 290,390 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of M.D.C. by 5.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 4,807,068 shares of the construction company’s stock valued at $131,813,000 after acquiring an additional 247,697 shares in the last quarter. River Road Asset Management LLC purchased a new stake in shares of M.D.C. in the 3rd quarter valued at about $4,391,000. Invesco Ltd. raised its holdings in shares of M.D.C. by 69.5% in the 1st quarter. Invesco Ltd. now owns 371,508 shares of the construction company’s stock valued at $14,057,000 after acquiring an additional 152,388 shares in the last quarter. Finally, Heartland Advisors Inc. purchased a new stake in shares of M.D.C. in the 3rd quarter valued at about $3,932,000. Institutional investors own 82.21% of the company’s stock.

M.D.C. Price Performance

Shares of MDC stock opened at $36.26 on Friday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 2.84 and a current ratio of 8.58. M.D.C. Holdings, Inc. has a fifty-two week low of $27.04 and a fifty-two week high of $43.88. The firm has a market cap of $2.65 billion, a P/E ratio of 4.73 and a beta of 1.36. The business’s 50 day moving average price is $36.65 and its 200-day moving average price is $32.78.

M.D.C. (NYSE:MDC – Get Rating) last released its earnings results on Tuesday, January 31st. The construction company reported $1.08 EPS for the quarter, missing the consensus estimate of $1.53 by ($0.45). M.D.C. had a return on equity of 19.24% and a net margin of 9.83%. The company had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.31 billion. During the same period last year, the firm posted $2.21 earnings per share. The company’s revenue was up 3.6% compared to the same quarter last year. On average, equities research analysts anticipate that M.D.C. Holdings, Inc. will post 2.61 earnings per share for the current year.

M.D.C. Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 22nd. Stockholders of record on Wednesday, February 8th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 5.52%. The ex-dividend date of this dividend was Tuesday, February 7th. M.D.C.’s dividend payout ratio is currently 26.08%.

Wall Street Analyst Weigh In

MDC has been the topic of several recent analyst reports. StockNews.com raised M.D.C. from a “sell” rating to a “hold” rating in a report on Friday, December 16th. Wedbush reissued a “neutral” rating on shares of M.D.C. in a report on Tuesday, February 7th. Finally, JPMorgan Chase & Co. decreased their price objective on M.D.C. from $30.50 to $27.50 and set an “underweight” rating on the stock in a report on Monday. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. According to data from MarketBeat.com, M.D.C. presently has an average rating of “Hold” and an average price target of $27.50.

Insider Transactions at M.D.C.

In other news, Director Herbert T. Buchwald sold 8,349 shares of the business’s stock in a transaction on Wednesday, March 8th. The stock was sold at an average price of $36.20, for a total value of $302,233.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, Director David E. Blackford sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 8th. The stock was sold at an average price of $38.35, for a total transaction of $115,050.00. Following the transaction, the director now owns 25,087 shares of the company’s stock, valued at $962,086.45. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Herbert T. Buchwald sold 8,349 shares of the company’s stock in a transaction on Wednesday, March 8th. The shares were sold at an average price of $36.20, for a total value of $302,233.80. The disclosure for this sale can be found here. Insiders sold 15,849 shares of company stock worth $582,299 over the last quarter. 23.30% of the stock is currently owned by insiders.

About M.D.C.

(Get Rating)

M.DC Holdings, Inc engages in proving homebuilding and financial services. It operates through the following business segments: West, Mountain, and East. The West segment includes operations in Arizona, California, Nevada, New Mexico, Oregon, Texas, and Washington. The Mountain segment refers to the operations in Colorado, Idaho, and Utah.